Atopic Dermatitis Market Expansion Supported by Next-Generation Biologic Drugs
The management of chronic inflammatory skin conditions has undergone a major transformation in recent years, particularly with the rise of biologics for atopic dermatitis. These advanced therapies are reshaping clinical outcomes for patients who do not respond adequately to conventional treatments. At the same time, growing demand for effective eczema medication and...
0 Comments 0 Shares 12 Views 0 Reviews